Clinuvel Pharmaceuticals Limited (ASX:CUV)
11.01
-0.03 (-0.27%)
Apr 24, 2025, 4:10 PM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 550.61 million as of April 24, 2025. Its market cap has decreased by -27.23% in one year.
Market Cap
550.61M
Enterprise Value
353.10M
Revenue
91.02M
Ranking
n/a
PE Ratio
14.31
Stock Price
11.01
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 550.61M, an increase of 10,436.60%. That is a compound annual growth rate of 21.21%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 114.55B |
Pro Medicus | 21.45B |
Cochlear | 17.02B |
Sonic Healthcare | 12.02B |
Telix Pharmaceuticals | 8.51B |
Ramsay Health Care | 7.54B |
Ansell | 4.14B |
Mesoblast | 2.06B |